Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

biokema s.a. - clostridium (c.) perfringens type a alpha toxoid, clostridium (c.) perfringens type a beta2 toxoid, clostridium (c.) perfringens type c beta1 toxoid, escherichia (e.) coli, fimbrial adhesins, inactivated, f4ab (k88ab), escherichia (e.) coli, fimbrial adhesins, inactivated, f4ac (k88ac), escherichia (e.) coli, fimbrial adhesins, inactivated, f5 (k99), escherichia (e.) coli, fimbrial adhesins, inactivated, f6 (987p) - lyophilisat et suspension pour préparation une suspension injectable pour porcs - praeparatio cryodesiccata: clostridium (c.) perfringens type a alpha toxoid ≥ 125 u., clostridium (c.) perfringens type a beta2 toxoid ≥ 794 u., clostridium (c.) perfringens type c beta1 toxoid ≥ 3354 u., saccharum, pro dosi. suspension: escherichia (e.) coli, fimbrial adhesins, inactivated, f4ab (k88ab) ≥ 23 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f4ac (k88ac) ≥ 19 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f5 (k99) ≥ 13 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f6 (987p) ≥ 37 u., aluminii oxidum hydricum 2 mg/ml, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile, ad suspensionem pro dosi 2 ml. - vaccin bactérien inactivé contre e. coli et les toxoïdes de clostridium chez les porcs - impfstoffe

Europäische Union - Deutsch - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - schweine - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ceva tiergesundheit gmbh (3123507) - clostridium-perfringens-typ-a-toxoid - injektionssuspension - clostridium-perfringens-typ-a-toxoid (35001) 125 elisa-einheit; clostridium-perfringens-typ-a-toxoid (35001) 770 elisa-einheit - kaninchen

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

idt biologika gmbh (4006040) - clostridium-perfringens-typ-a-toxoid; clostridium perfringens, typ a, beta2 toxoid - injektionssuspension - clostridium-perfringens-typ-a-toxoid (35001) 125 elisa-einheit; clostridium perfringens, typ a, beta2 toxoid (38656) 770 elisa-einheit - zuchtsau; schwein

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

idt biologika gmbh (4006040) - clostridium-perfringens-typ-a-toxoid - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension - clostridium-perfringens-typ-a-toxoid (35001) 125 relative einheit; clostridium-perfringens-typ-a-toxoid (35001) 770 relative einheit - schwein

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international - clostridium haemolyticum-toxoid; clostridium tetani-toxoid; clostridium novyi-toxoid; clostridium chauvoei; clostridium perfringens; clostridium sordellii-toxoid - injektionssuspension - clostridium haemolyticum-toxoid ; clostridium tetani-toxoid ; clostridium novyi-toxoid ; clostridium chauvoei ; clostridium perfringens ; clostridium sordellii-toxoid - clostridium - rind; schaf

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

idt biologika - clostridium perfringens - injektionssuspension - clostridium perfringens - clostridium - schwein

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - clostridium chauvoei-septicum; clostridium haemolyticum-toxoid; clostridium novyi-toxoid; clostridium perfringens; clostridium tetani-toxoid; clostridium sordellii-toxoid - injektionssuspension - clostridium chauvoei-septicum ; clostridium haemolyticum-toxoid ; clostridium novyi-toxoid ; clostridium perfringens ; clostridium tetani-toxoid ; clostridium sordellii-toxoid - clostridium - rind; schaf

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

idt biologika - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - clostridium - schwein

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

idt biologika - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - clostridium - schwein